Your browser doesn't support javascript.
loading
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone, Nora M; van Weerden, Wytske M; Vessella, Robert L; Williams, Elizabeth D; Wang, Yuzhuo; Isaacs, John T; Nguyen, Holly M; Culig, Zoran; van der Pluijm, Gabri; Rentsch, Cyril A; Marques, Rute B; de Ridder, Corrina M A; Bubendorf, Lukas; Thalmann, George N; Brennen, William Nathaniel; Santer, Frédéric R; Moser, Patrizia L; Shepherd, Peter; Efstathiou, Eleni; Xue, Hui; Lin, Dong; Buijs, Jeroen; Bosse, Tjalling; Collins, Anne; Maitland, Norman; Buzza, Mark; Kouspou, Michelle; Achtman, Ariel; Taylor, Renea A; Risbridger, Gail; Corey, Eva.
Afiliação
  • Navone NM; MD Anderson Cancer Center, Houston, Texas.
  • van Weerden WM; Erasmus Medical Center, Rotterdam, The Netherlands.
  • Vessella RL; University of Washington, Seattle, Washington.
  • Williams ED; Queensland University of Technology and Australian Prostate Cancer Research Centre-Queensland, Brisbane City, Australia.
  • Wang Y; Vancouver Prostate Cancer Centre, Department of Urological Sciences, UBC, Vancouver, Canada.
  • Isaacs JT; Johns Hopkins University, Baltimore, Maryland.
  • Nguyen HM; University of Washington, Seattle, Washington.
  • Culig Z; Innsbruck Medical University, Innsbruck, Austria.
  • van der Pluijm G; Leiden University Medical Center, Leiden, The Netherlands.
  • Rentsch CA; University Hospital Basel, Basel, Switzerland.
  • Marques RB; Erasmus Medical Center, Rotterdam, The Netherlands.
  • de Ridder CMA; Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bubendorf L; University Hospital Basel, Basel, Switzerland.
  • Thalmann GN; University Hospital Bern Inselspital, Bern, Switzerland.
  • Brennen WN; Johns Hopkins University, Baltimore, Maryland.
  • Santer FR; Innsbruck Medical University, Innsbruck, Austria.
  • Moser PL; Innsbruck Medical University, Innsbruck, Austria.
  • Shepherd P; MD Anderson Cancer Center, Houston, Texas.
  • Efstathiou E; MD Anderson Cancer Center, Houston, Texas.
  • Xue H; Vancouver Prostate Cancer Centre, Department of Urological Sciences, UBC, Vancouver, Canada.
  • Lin D; Vancouver Prostate Cancer Centre, Department of Urological Sciences, UBC, Vancouver, Canada.
  • Buijs J; Leiden University Medical Center, Leiden, The Netherlands.
  • Bosse T; Leiden University Medical Center, Leiden, The Netherlands.
  • Collins A; University of York, York, UK.
  • Maitland N; University of York, York, UK.
  • Buzza M; Movember Foundation, Melbourne, Australia.
  • Kouspou M; Movember Foundation, Melbourne, Australia.
  • Achtman A; Movember Foundation, Melbourne, Australia.
  • Taylor RA; Monash University, Melbourne, Australia.
  • Risbridger G; Monash University, Melbourne, Australia.
  • Corey E; University of Washington, Seattle, Washington.
Prostate ; 78(16): 1262-1282, 2018 12.
Article em En | MEDLINE | ID: mdl-30073676

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ensaios Antitumorais Modelo de Xenoenxerto / Xenoenxertos / Transplante de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ensaios Antitumorais Modelo de Xenoenxerto / Xenoenxertos / Transplante de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos